1. Cell Biology
  2. Developmental Biology
Download icon

Cell Cycle: Deciding when to exit

  1. Joy H Meserve
  2. Robert J Duronio  Is a corresponding author
  1. Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, United States
  2. Department of Biology, University of North Carolina, United States
  3. Department of Genetics, University of North Carolina, United States
  4. Lineberger Comprehensive Cancer Center, University of North Carolina, United States
  5. Integrative Program for Biological and Genome Sciences, University of North Carolina, United States
Insight
  • Cited 0
  • Views 1,675
  • Annotations
Cite this article as: eLife 2021;10:e66591 doi: 10.7554/eLife.66591

Abstract

A new imaging approach can distinguish between cells destined to stop proliferating and those committed to re-entering the cell cycle in live animals.

Main text

The development and survival of a multicellular organism relies on cells proliferating by passing through a series of events known as the cell cycle. During the first stage of the cycle (G1), each cell makes an important decision: does it progress to the second stage (S-phase) and replicate its genome in preparation for cell division, or does it exit the cycle and become quiescent (Pardee, 1974; Johnson and Skotheim, 2013)?

Cells usually exit the cell cycle in order to differentiate into the distinct cell types of an organism, such as neurons, muscle or fat (Sun and Buttitta, 2017). If the decision to stop proliferating is somehow disrupted, this can affect the normal development or function of tissues and organs and lead to diseases, such as cancer. However, understanding the signals that control this decision can be challenging because a G1 cell preparing to enter S-phase is essentially indistinguishable from a G1 cell that will become quiescent.

One way to overcome this challenge is to visually monitor proteins that are only active in certain phases of the cell cycle (Sakaue-Sawano et al., 2008; Zielke et al., 2014; Grant et al., 2018). For example, a group of proteins called cyclin-dependent kinases (or CDKs for short), which drive cells into S-phase, are active in G1 but are permanently turned off when cells enter a state of quiescence.

In 2013, a group of researchers used this property of CDKs to distinguish cultured mammalian cells in G1 that were preparing to proliferate from those entering quiescence (Spencer et al., 2013). To do this they engineered a fluorescent reporter protein which sits in the nucleus when CDKs are inactive and moves into the cytoplasm when modified by active CDKs (Figure 1A). The nucleus and cytoplasm are easily distinguishable via time-lapse microscopy, making it possible to determine when CDKs are active in individual cells during G1.

Monitoring cell cycle progression using a fluorescent biosensor.

(A) As cells grow and prepare to divide they pass through four different phases of the cell cycle: G1, S, G2, M. During the course of this cycle, the activity of cyclin-dependent kinases (CDKs) changes. These fluctuations in activity can be monitored using a fluorescent reporter protein that contains a portion of human DNA helicase B (DHB), which moves from the nucleus to the cytoplasm when phosphorylated by active CDKs. Thus, changes in the levels of DHB in the nucleus and cytoplasm (depicted in shades of orange/red) can be used to determine a cell’s CDK activity. At the start of G1, CDK activity is low and DHB remains in the nucleus (shown in red). Some G1 cells maintain this low level of activity (CDKlow) and exit the cell cycle to become quiescent, while cells with increasing levels of CDK activity (CDKinc) commit to another cell cycle and enter S-phase. (B) Adikes et al. showed that the DHB reporter could monitor cell cycle progression of individual cells in live animals, such as the embryo of a zebrafish. It can also identify which cells have exited the cell cycle and which are preparing for division.

Image credit: Joy H Meserve.

Now, in eLife, David Matus from Stony Brook University and co-workers – including Rebecca Adikes, Abraham Kohrman, and Michael Martinez as joint first authors – report how they used this technique to visualize when individual cells decide to stop dividing in living animals (Adikes et al., 2020). To adapt the CDK reporter to animals, the team (who are based at Stony Brook, the University of Colorado, Stanford University, Imperial College and University of Virginia) turned to two well studied experimental organisms: the nematode worm C. elegans and the zebrafish D. rerio.

Previous work using the CDK reporter in cultured mammalian cells showed that not all G1 cells behave the same after cell division: some never activate CDKs and enter quiescence (CDKlow cells), while others begin increasing CDK activity during G1 (CDKinc cells) and ultimately commit to another cell cycle (Figure 1A; Spencer et al., 2013). Adikes et al. found that this bifurcation in G1 cells could also be detected in the tissues of living C. elegans and D. rerio (Figure 1B). They found that the CDKlow and CDKinc phenotypes of G1 cells could be used to predict whether a cell would enter quiescence or would re-commit to another cycle. Further experiments revealed that if a cell had high levels of a protein called p21, which inhibits the activity of CDKs, its daughter cells were more likely to become quiescent following division. This suggests that the decision to proliferate or exit the cell cycle may depend on how p21 levels are regulated in proliferating cells (Overton et al., 2014; Hsu et al., 2019).

The CDK reporter has a number of applications. It could make it easier to study how quiescence is regulated in tissues that are typically difficult to image for long periods of time. It might reveal early steps in tissue regeneration when cells are ramping up to re-enter the cell cycle. It could also be used to sort and recover populations of CDKlow and CDKinc cells for further experiments to identify the pathways regulating entry into quiescence.

The CDK reporter will allow us to tackle many interesting questions in developmental biology. For instance, how might the organization of a tissue influence the decision to stop dividing and enter quiescence? Is it possible to identify cells very early in the differentiation process before genes that demark differentiation turn on? Whatever the application or research question, Adikes et al. demonstrate once again that important new insights into the complexities of biology arise when new tools are developed to visualize living organisms.

References

Article and author information

Author details

  1. Joy H Meserve

    Joy H Meserve is in the Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States

    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5073-6337
  2. Robert J Duronio

    Robert J Duronio is in the Integrative Program for Biological and Genome Sciences, Department of Biology, Department of Genetics, and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, United States

    For correspondence
    duronio@med.unc.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6469-6965

Publication history

  1. Version of Record published: February 12, 2021 (version 1)

Copyright

© 2021, Meserve and Duronio

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,675
    Page views
  • 104
    Downloads
  • 0
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Cell Biology
    Joël Lemière et al.
    Research Article

    During clathrin-mediated endocytosis in eukaryotes, actin assembly is required to overcome large membrane tension and turgor pressure. However, the molecular mechanisms by which the actin machinery adapts to varying membrane tension remain unknown. In addition, how cells reduce their membrane tension when they are challenged by hypotonic shocks remains unclear. We used quantitative microscopy to demonstrate that cells rapidly reduce their membrane tension using three parallel mechanisms. In addition to using their cell wall for mechanical protection, yeast cells disassemble eisosomes to buffer moderate changes in membrane tension on a minute time scale. Meanwhile, a temporary reduction of the rate of endocytosis for 2 to 6 minutes, and an increase in the rate of exocytosis for at least 5 minutes allow cells to add large pools of membrane to the plasma membrane. We built on these results to submit the cells to abrupt increases in membrane tension and determine that the endocytic actin machinery of fission yeast cells rapidly adapts to perform clathrin-mediated endocytosis. Our study sheds light on the tight connection between membrane tension regulation, endocytosis and exocytosis.

    1. Cancer Biology
    2. Cell Biology
    Alvaro Gonzalez Rajal et al.
    Research Advance

    We previously used a pulse-based in vitro assay to unveil targetable signalling pathways associated with innate cisplatin resistance in lung adenocarcinoma (Hastings et al., 2020). Here we advanced this model system and identified a non-genetic mechanism of resistance that drives recovery and regrowth in a subset of cells. Using RNAseq and a suite of biosensors to track single cell fates both in vitro and in vivo, we identified that early S phase cells have a greater ability to maintain proliferative capacity, which correlated with reduced DNA damage over multiple generations. In contrast, cells in G1, late S or those treated with PARP/RAD51 inhibitors, maintained higher levels of DNA damage and underwent prolonged S/G2 phase arrest and senescence. Combined with our previous work, these data indicate that there is a non-genetic mechanism of resistance in human lung adenocarcinoma that is dependent on the cell cycle stage at the time of cisplatin exposure.